Zhonggui He

机构：Shenyang Pharmaceutical University

发表论文 20 篇 · 总被引 409 次 · h-index 9

代表论文

• Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery (2009 · Recent Patents on Anti-Cancer Drug Discovery · 被引 158)
• Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy (2017 · Drug Delivery · 被引 53)
• Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency (2020 · Acta Pharmaceutica Sinica B · 被引 45)
• Recent advances in SN-38 drug delivery system (2023 · International Journal of Pharmaceutics · 被引 37)
• Cancer Cell Membrane-Coated Homodimer Prodrug Nanoassemblies to Simultaneously Deliver Prodrugs and Immune Adjuvants for Combined Chemo-Immunotherapy (2025 · ACS Nano · 被引 29)
• Galloylated liposomes enable targeted drug delivery by overcoming protein corona shielding (2025 · Nature Communications · 被引 17)